Literature DB >> 12672108

Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.

Michael Keller1, Richard P Harbottle, Eric Perouzel, Morvane Colin, Imran Shah, Ahad Rahim, Laurence Vaysse, Anna Bergau, Sylviane Moritz, Christiane Brahimi-Horn, Charles Coutelle, Andrew D Miller.   

Abstract

The impact of a peptide that contains a nuclear localisation sequence (NLS) on intracellular DNA trafficking was studied. We used the adenoviral core peptide mu and an SV40 NLS peptide to condense plasmid DNA (pDNA) prior to formulation with 3beta-[N-(N', N'-dimethylaminoethane)carbamoyl]cholesterol/dioleoyl-L-alpha-phosphatidyl ethanolamine (DC-Chol/DOPE) liposomes to give LMD and LND vectors, respectively. Fluorescent-labelled lipid and peptides plus dye-labelled pDNA components were used to investigate gene delivery in dividing and S-phase growth-arrested cells. Confocal microscopic analyses reveal little difference in intracellular trafficking events. Strikingly, mu peptide associates with nuclei and nucleoli of cells within less than 15 mins incubation of LMD with cells, which suggests that mu peptide has an NLS function. These NLS properties were confirmed by cloning of a mu-beta-galactosidase fusion protein that localises in the nuclei of cells after cytosolic translation. In dividing cells both LMD and LND deliver pDNA(Cy3) to nuclei within 30-45 min incubation with cells. By contrast, pDNA is detected only in the cytoplasm in growth-arrested cells over the period of time investigated, and not in the nuclei. LD systems prepared from DC-Chol/DOPE cationic liposomes and pDNA(Cy3) behave similarly to LMD systems, which suggests that mu peptide is unable to influence trafficking events in this current LMD formulation, in spite of its strong NLS capacity. We further describe the effect of polyethyleneglycol (PEG) on cellular uptake. "Stealth" systems obtained by post-coating LMD particles with fluorescent-labelled PEG molecules (0.5, 5 and 10 mol % fluorescein-PEG(5000)-N-hydroxysuccinimide) were prepared and shown to be internalised rapidly (mins) by cells, without detectable transgene expression. This result indicates that PEG blocks intracellular trafficking of pDNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672108     DOI: 10.1002/cbic.200390049

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  11 in total

Review 1.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

Review 2.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 3.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

4.  Stabilized nonviral formulations for the delivery of MCP-1 gene into cells of the vasculoendothelial system.

Authors:  Martin C Lenter; Patrick Garidel; Jaroslav Pelisek; Ernst Wagner; Manfred Ogris
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

5.  HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.

Authors:  Yuhua Wang; Brenda F Canine; Arash Hatefi
Journal:  Nanomedicine       Date:  2010-10-01       Impact factor: 5.307

6.  Use of RecA fusion proteins to induce genomic modifications in zebrafish.

Authors:  Hsin-Kai Liao; Jeffrey J Essner
Journal:  Nucleic Acids Res       Date:  2011-01-25       Impact factor: 16.971

7.  Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.

Authors:  Federico Perche; Vladimir P Torchilin
Journal:  J Drug Deliv       Date:  2013-03-07

8.  Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex.

Authors:  Susumu Hama; Hidetaka Akita; Shinya Iida; Hiroyuki Mizuguchi; Hideyoshi Harashima
Journal:  Nucleic Acids Res       Date:  2007-02-07       Impact factor: 16.971

9.  Nuclear accumulation of plasmid DNA can be enhanced by non-selective gating of the nuclear pore.

Authors:  Roosmarijn E Vandenbroucke; Bart Lucas; Joseph Demeester; Stefaan C De Smedt; Niek N Sanders
Journal:  Nucleic Acids Res       Date:  2007-06-21       Impact factor: 16.971

Review 10.  Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's Disease.

Authors:  Wei Chen; Hui Li; Zhenguo Liu; Weien Yuan
Journal:  Front Aging Neurosci       Date:  2016-04-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.